Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
Cytochrome 2C9 (CYP2C9), one of the most important drug metabolic enzymes in the human hepatic P450 superfamily, is required for the metabolism of 15% of clinical drugs. Similar to other CYP2C family members, CYP2C9 gene has a high genetic polymorphism which can cause significant racial and inter-in...
Main Authors: | Fang-Ling Zhao, Qing Zhang, Shuang-Hu Wang, Yun Hong, Shan Zhou, Quan Zhou, Pei-Wu Geng, Qing-Feng Luo, Jie-Fu Yang, Hao Chen, Jian-Ping Cai, Da-Peng Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1007268/full |
Similar Items
-
Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects
by: Qing Zhang, et al.
Published: (2023-03-01) -
Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population
by: Dongxu Wang, et al.
Published: (2022-11-01) -
Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro
by: Li-Li Zou, et al.
Published: (2023-05-01) -
Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations
by: Sara Flores-Gutiérrez, et al.
Published: (2017-02-01) -
Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol
by: Pil Joung Cho, et al.
Published: (2018-08-01)